Chemical Toxicants Activate Murine Ovarian Ascitic Tumor Cells for In Situ Lipofection

REFERENCES

• Ausubel, F. M., R. Brent, R. E. Kingston, and D. D. Moore. 1991. Chloram- phenicol acetyltransferas e assay. In Current protocol s in molecular biology, vol. 1, 9.6.2-9.6.5. Boston: Wiley.
   Google Scholar
• Backway, K. L., E. A. McCulloch, S. Chow, and D. W. Hedley. 1997. Relation- ships between the mitochondria l permeability transition and oxidative stress during ara-C toxicity. Cancer Res. 57:2446–2451.
   PubMed Web of Science ®Google Scholar
• Behl, C., T. Sketella, F. Lezoualch, A. Post, M. Widmann, C. J. Newton, and
   Google Scholar
• F. Holsboer. 1997. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 51:535–541.
   PubMed Web of Science ®Google Scholar
• Buttke, T. M., and P. A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7–10.
   PubMedGoogle Scholar
• Fekete, E., and M. A. Ferrigno. 1952. Studies on a transplantabl e teratoma of the mouse. Cancer Res. 12:438–443.
   PubMed Web of Science ®Google Scholar
• Felman, G. B., R. C. Knapp, S. E. Order, and S. Hellman. 1972. The role of lym- phatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res. 32:1663–1666.
   PubMed Web of Science ®Google Scholar
• Fichtinger-Schepman, A. M. J., J. L. Van der Veer, J. H. J. den Hartog,
   Google Scholar
• P. H. M. Lohman, and J. Reedijk. 1985. Adducts of the antitumor drug cis- diaminedichloroplatinum(II) with DNA: Formation, identification and quan- titation. Biochemistry 24:707–713.
   PubMed Web of Science ®Google Scholar
• Gao, X., and L. Huang. 1992. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:280- 285.
   Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinatio n genome s which express chloramphenico l acetyltransferas e in mammalian cells. Mol. Cell Biol. 2:1044–1055.
   PubMed Web of Science ®Google Scholar
• Gundimeda, U., Z. H. Chen, and R. Gepalakrishna. 1996. Tamoxifen modu- lates protein kinase C via oxidative stress in estrogen receptor-negativ e breast cancer cells. J. Biol. Chem. 271:13504– 13514.
   PubMed Web of Science ®Google Scholar
• Huang, L., K. Son, X. Gao, D. Hages, Y. Y. Yang, S. A. Holden, S. A. Teicher,
   Google Scholar
• J. Kirkwood, and J. S. Lazo. 1996. Efficient lipofection with Cisplatin resistant human tumor cells, Cancer Gene Ther. 3:107–112.
   PubMed Web of Science ®Google Scholar
• Hug, H., M. Enari, and S. Nagata. 1994. No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett. 351:311 -313.
   Google Scholar
• Kojima, T., T. Mitaka, C. Mochizuki, and Y. Mochizuki. 1996. Effects of oxygen radical scavenger s on connexins 32 and 26 expression in primary cultures of adult rat hepatocytes. Carcinogenesis 17:537–544.
   PubMed Web of Science ®Google Scholar
• Look, M. P., and E. Musch. 1994. Lipid peroxides in the polychemotherap y of cancer patients. Chemotherapy 40:8–15.
   PubMed Web of Science ®Google Scholar
• Moorehead, R. A., S. G. Armstrong, B. C. Wilson, and G. Singh. 1994. Cross- resistance to cisplatin in cells resistant to photofrin-mediate d photodynami c therapy. Cancer Res. 54:2556–2559.
   PubMed Web of Science ®Google Scholar
• Nie, Z., Y. Mei, M. Ford, L. Rybak, A. Marcuzzi, H. Ren, G. L. Stiles, and
   Google Scholar
• V. Ramkumar. 1998. Oxidative stress increases A1 adenosin e receptor ex- pression by activating nuclear factor kappaB. Mol. Pharmacol. 53:663- 669.
   Web of Science ®Google Scholar
• Plautz, G. E., Z.-Y. Yang, B.-Y. Wu, X. Gao, and L. Huang. 1993. Immunotherap y of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA 90:4645–4649.
   PubMed Web of Science ®Google Scholar
• Plummer, J. L., B. R. Smith, H. Sies, and J. R. Bend. 1981. Chemical depletion of glutathione in vivo. In Methods in enzymology, ed. W. B. Jakoby, vol. 7, 50–59. San Diego: Academic Press.
   Google Scholar
• Sandau, K., J. Pfeilschifter, and B. Brune. 1998. Nitrosative and oxidative stress induced heme oxygenase- 1 accumulatio n in rat mesangia l cells. Eur. J. Phar- macol. 342:77–84.
   PubMed Web of Science ®Google Scholar
• Sies H. 1988. Oxidative stress: Quinone redox cycling. ISI Atlas Sci. Biochem. 1:109–114.
   Web of Science ®Google Scholar
• Singal, A., and L. Huang. 1994. Gene transfer in mammalian cells using lipo- somes as carriers. In Gene therapeutics, ed. J. A. Wolff, 118–142. Boston: Birkhauser.
   Google Scholar
• Spitz, D. R., J. W. Phillips, D. T. Adams, C. M. Sherman, D. F. Deen, and G. C. Li. 1993. Cellular resistance to oxidative stress is accompanie d by resistance to cisplatin: The significance of increased catalase activity and total glutathione in hydroge n peroxide-resistan t fibroblasts. J. Cell. Physiol. 156: 72–79.
   PubMed Web of Science ®Google Scholar
• Son, K. 1997a. Cisplatin-based interferonc gene therapy of murine ovarian carcinoma. Cancer Gene Ther. 4:391–396.
   PubMed Web of Science ®Google Scholar
• Son, K. 1997b. Cellular resistance to oxidative stress enhance s in vitro and in situ liposome-mediate d gene transfer. Int. J. Oncol. 10:1057–1060.
   PubMed Web of Science ®Google Scholar
• Son, K., and L. Huang. 1994. Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediate d gene transfer. Proc. Natl. Acad. Sci. USA 91:12669– 12672.
   PubMed Web of Science ®Google Scholar
• Son, K., and L. Huang. 1996. Factors in¯uencing the drug sensitization of human tumor cells for in situ lipofection. Gene Therapy 3:630–634.
   PubMed Web of Science ®Google Scholar
• Son, K., and Y.-M. Kim. 1995. In vivo cisplatin-expose d macrophage s increase immunostimulant-induce d nitric oxide synthesis for tumor cell killing. Cancer Res. 55:5524– 5527.
   PubMed Web of Science ®Google Scholar